(Q30334472)

18 June 2017

1 reference

title

Drug treatment of tuberculosis--1992 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1379145

20 September 2022

0 references

P. T. Davidson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1379145

20 September 2022

H. Q. Le

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1379145

20 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1379145

20 September 2022

publication date

1 May 1992

1 reference

18 June 2017

1 reference

18 June 2017

43

1 reference

18 June 2017

5

1 reference

18 June 2017

651-673

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199243050-00003

18 June 2017

0 references

cites work

In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii

1 reference

12 December 2020

American Thoracic Society. Medical Section of the American Lung Association: Treatment of tuberculosis and tuberculosis infection in adults and children

1 reference

12 December 2020

In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis

1 reference

12 December 2020

Distribution of ethambutol in primate tissues and cells

1 reference

12 December 2020

Treatment of tuberculosis during pregnancy

1 reference

12 December 2020

Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide

1 reference

12 December 2020

Clinical pharmacology of ethambutol

1 reference

12 December 2020

In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis

1 reference

12 December 2020

The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis

1 reference

12 December 2020

Clofazimine and other rimino-compounds: minimal inhibitory and minimal bactericidal concentrations at different pHs for Mycobacterium avium complex

1 reference

12 December 2020

Tissue distribution of [14C]ethambutol in mice

1 reference

12 December 2020

Suicide by rifampin overdose

1 reference

12 December 2020

Drug-resistant Mycobacterium tuberculosis in Korean isolates

1 reference

12 December 2020

Mycobacterium tuberculosis infection in the acquired immunodeficiency syndrome. A review of 14 patients

1 reference

12 December 2020

A second international co-operative investigation into thiacetazone side-effects. Rashes on two thiacetazone containing regimens

1 reference

12 December 2020

Human immunodeficiency virus infection in tuberculosis patients

1 reference

12 December 2020

Activation of pyrazinamide and nicotinamide in acidic environments in vitro.

1 reference

12 December 2020

In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin

1 reference

12 December 2020

Concentrations of ethambutol in the cerebrospinal fluid after oral administration

1 reference

12 December 2020

Twenty isoniazid-associated deaths in one state

1 reference

12 December 2020

Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.

1 reference

12 December 2020

Single High-Dose Pyridoxine Treatment for Isoniazid Overdose

1 reference

12 December 2020

Rifampin concentrations in cerebrospinal fluid of patients with tuberculous meningitis

1 reference

12 December 2020

Mode of action of ethambutol on Mycobacterium tuberculosis, strain H37R V.

1 reference

12 December 2020

Failure of "optimal" four-drug short-course tuberculosis chemotherapy in a compliant patient with human immunodeficiency virus

1 reference

12 December 2020

A Controlled Trial of 3-Month, 4-Month, and 6-Month Regimens of Chemotherapy for Sputum-smear-negative Pulmonary Tuberculosis: Results at 5 Years

1 reference

12 December 2020

Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages

1 reference

12 December 2020

Double blind controlled comparison of aspirin, allopurinol and placebo in the management of arthralgia during pyrazinamide administration

1 reference

12 December 2020

Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis

1 reference

12 December 2020

An international co-operative investigation into thiacetazone (thioacetazone) side-effects.

1 reference

12 December 2020

Adverse effects of antituberculosis drugs

1 reference

12 December 2020

USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results

1 reference

12 December 2020

Antituberculosis activity in the phenazine series. II. N3-substituted anilinoaposafranines (rimino-compounds) and some derivatives

1 reference

12 December 2020

Tuberculosis and acquired immunodeficiency syndrome--New York City.

1 reference

12 December 2020

Tuberculosis in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival

1 reference

12 December 2020

The effect of ethambutol on tubercle bacilli within cultured human macrophages

1 reference

12 December 2020

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

1 reference

12 December 2020

Rheumatoid syndrome during isoniazid therapy

1 reference

12 December 2020

Bacteriologic basis of short-course chemotherapy for tuberculosis.

1 reference

12 December 2020

The early bactericidal activity of drugs in patients with pulmonary tuberculosis

1 reference

12 December 2020

In vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic: RU-28965.

1 reference

12 December 2020

Fatal rifampicin-ethambutol overdosage

1 reference

12 December 2020

In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test

1 reference

12 December 2020

Amikacin in the treatment of pulmonary tuberculosis

1 reference

12 December 2020

Pyrazinamide and other drugs in tuberculous meningitis.

1 reference

12 December 2020

The Experimental Properties of G 30 320 (B 663) - a New Anti-leprotic Agent

1 reference

12 December 2020

In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin

1 reference

12 December 2020

Ofloxacin and warfarin

1 reference

12 December 2020

Interaction of rifampicin with other drugs

1 reference

12 December 2020

Whither short-course chemotherapy?

1 reference

12 December 2020

Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex

1 reference

12 December 2020

Human bioavailability studies

1 reference

12 December 2020

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

1 reference

12 December 2020

Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis.

1 reference

12 December 2020

[Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse]

1 reference

12 December 2020

Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments

1 reference

12 December 2020

Should women taking antituberculosis drugs breast-feed?

1 reference

12 December 2020

Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial

1 reference

12 December 2020

Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods

1 reference

12 December 2020

Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.

1 reference

12 December 2020

The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide

1 reference

12 December 2020

Mycobacterioses and the acquired immunodeficiency syndrome. Joint Position Paper of the American Thoracic Society and the Centers for Disease Control

1 reference

12 December 2020

Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS

1 reference

12 December 2020

The Antituberculosis Efficacy of Rifampin in 136 Patients

1 reference

12 December 2020

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

1 reference

12 December 2020

The effects of exposure time, drug concentration, and temperature on the activity of ethambutol versus Mycobacterium tuberculosis.

1 reference

12 December 2020

Corticosteroids in treatment of disseminated tuberculosis in patient with HIV infection

1 reference

12 December 2020

Acute rifampin overdose: A pharmacokinetic study and review of the literature

1 reference

12 December 2020

Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative

1 reference

12 December 2020

Drug combinations and the bioavailability of rifampicin

1 reference

12 December 2020

The use of pyrazinamide plus isoniazid in the treatment of pulmonary tuberculosis

1 reference

12 December 2020

Intentional isoniazid overdosage in young Southeast Asian refugee women

1 reference

12 December 2020

10.2165/00003495-199243050-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

18 June 2017

0 references

1 reference